A Study of Glutamine to Treat Intestinal Permeability in Functional Dyspepsia
Status:
Not yet recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this research is to collect data from patients diagnosed with functional
dyspepsia who are treated with glutamine and describe safety and treatment results compared
to patients taking a placebo. Glutamine, an essential amino acid in humans, is an important
energy source for cells lining the gastrointestinal tract and has been shown to play an
important role in regulating the strength of the intestinal wall.